Doxecitine and Doxribtimine-Expanded Access
Latest Information Update: 01 Oct 2024
At a glance
- Drugs Deoxycytidine/deoxythymidine (Primary)
- Indications Mitochondrial disorders
- Focus Expanded access; Therapeutic Use
- Sponsors UCB Biosciences
- 01 Oct 2024 New trial record